Together, these data suggest that only BDP1 of the TFIIIB complex has expression correlating with stages II, III and IV in serous ovarian cancer (Figure 3A) which interestingly, is similar to BRCA1 (Figure 3F) and BRCA2 (Figure 3G), established drivers of serous ovarian cancer.6, 53. Here, BDP1 is linked to ovarian serous adenocarcinoma.